Literature DB >> 28515294

Deletion of the Vaccinia Virus B1 Kinase Reveals Essential Functions of This Enzyme Complemented Partly by the Homologous Cellular Kinase VRK2.

Annabel T Olson1,2, Amber B Rico1,3, Zhigang Wang1, Gustavo Delhon3, Matthew S Wiebe4,3.   

Abstract

The vaccinia virus B1 kinase is highly conserved among poxviruses and is essential for the viral life cycle. B1 exhibits a remarkable degree of similarity to vaccinia virus-related kinases (VRKs), a family of cellular kinases, suggesting that the viral enzyme has evolved to mimic VRK activity. Indeed, B1 and VRKs have been demonstrated to target a shared substrate, the DNA binding protein BAF, elucidating a signaling pathway important for both mitosis and the antiviral response. In this study, we further characterize the role of B1 during vaccinia infection to gain novel insights into its regulation and integration with cellular signaling pathways. We begin by describing the construction and characterization of the first B1 deletion virus (vvΔB1) produced using a complementing cell line expressing the viral kinase. Examination of vvΔB1 revealed that B1 is critical for the production of infectious virions in various cell types and is sufficient for BAF phosphorylation. Interestingly, the severity of the defect in DNA replication following the loss of B1 varied between cell types, leading us to posit that cellular VRKs partly complement for the absence of B1 in some cell lines. Using cell lines devoid of either VRK1 or VRK2, we tested this hypothesis and discovered that VRK2 expression facilitates DNA replication and allows later stages of the viral life cycle to proceed in the absence of B1. Finally, we present evidence that the impact of VRK2 on vaccinia virus is largely independent of BAF phosphorylation. These data support a model in which B1 and VRK2 share additional substrates important for the replication of cytoplasmic poxviruses.IMPORTANCE Viral mimicry of cellular signaling modulators provides clear evidence that the pathogen targets an important host pathway during infection. Poxviruses employ numerous viral homologs of cellular proteins, the study of which have yielded insights into signaling pathways used by both virus and cells alike. The vaccinia virus B1 protein is a homolog of cellular vaccinia virus-related kinases (VRKs) and is needed for viral DNA replication and likely other stages of the viral life cycle. However, much remains to be learned about how B1 and VRKs overlap functionally. This study utilizes new tools, including a B1 deletion virus and VRK knockout cells, to further characterize the functional links between the viral and cellular enzymes. As a result, we have discovered that B1 and VRK2 target a common set of substrates vital to productive infection of this large cytoplasmic DNA virus.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  B1R; BAF; BANF1; VRK2; poxviruses; protein kinases; vaccinia

Mesh:

Substances:

Year:  2017        PMID: 28515294      PMCID: PMC5512240          DOI: 10.1128/JVI.00635-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Barrier-to-autointegration factor (BAF) bridges DNA in a discrete, higher-order nucleoprotein complex.

Authors:  R Zheng; R Ghirlando; M S Lee; K Mizuuchi; M Krause; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  Plk3 interacts with and specifically phosphorylates VRK1 in Ser342, a downstream target in a pathway that induces Golgi fragmentation.

Authors:  Inmaculada López-Sánchez; Marta Sanz-García; Pedro A Lazo
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

3.  Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus.

Authors:  R C Condit; A Motyczka; G Spizz
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

4.  Genomes of the parapoxviruses ORF virus and bovine papular stomatitis virus.

Authors:  G Delhon; E R Tulman; C L Afonso; Z Lu; A de la Concha-Bermejillo; H D Lehmkuhl; M E Piccone; G F Kutish; D L Rock
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

5.  The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus.

Authors:  R Jeremy Nichols; Matthew S Wiebe; Paula Traktman
Journal:  Mol Biol Cell       Date:  2006-02-22       Impact factor: 4.138

6.  Vaccinia virus gene H5R encodes a protein that is phosphorylated by the multisubstrate vaccinia virus B1R protein kinase.

Authors:  G Beaud; R Beaud; D P Leader
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

7.  Vaccinia virus recombinants expressing rabiesvirus glycoprotein protect against rabies.

Authors:  J Esposito; K Brechling; G Baer; B Moss
Journal:  Virus Genes       Date:  1987-11       Impact factor: 2.332

8.  Members of a novel family of mammalian protein kinases complement the DNA-negative phenotype of a vaccinia virus ts mutant defective in the B1 kinase.

Authors:  Kathleen A Boyle; Paula Traktman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  The conserved kinase NHK-1 is essential for mitotic progression and unifying acentrosomal meiotic spindles in Drosophila melanogaster.

Authors:  C Fiona Cullen; Amy L Brittle; Takashi Ito; Hiroyuki Ohkura
Journal:  J Cell Biol       Date:  2005-11-21       Impact factor: 10.539

10.  Néstor-Guillermo Progeria Syndrome: a biochemical insight into Barrier-to-Autointegration Factor 1, alanine 12 threonine mutation.

Authors:  Nicolas Paquet; Joseph K Box; Nicholas W Ashton; Amila Suraweera; Laura V Croft; Aaron J Urquhart; Emma Bolderson; Shu-Dong Zhang; Kenneth J O'Byrne; Derek J Richard
Journal:  BMC Mol Biol       Date:  2014-12-12       Impact factor: 2.946

View more
  7 in total

1.  The Vaccinia Virus (VACV) B1 and Cellular VRK2 Kinases Promote VACV Replication Factory Formation through Phosphorylation-Dependent Inhibition of VACV B12.

Authors:  Amber B Rico; Zhigang Wang; Annabel T Olson; Alexandria C Linville; Brianna L Bullard; Eric A Weaver; Clinton Jones; Matthew S Wiebe
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

2.  The Vaccinia Virus B12 Pseudokinase Represses Viral Replication via Interaction with the Cellular Kinase VRK1 and Activation of the Antiviral Effector BAF.

Authors:  Amber B Rico; Alexandria C Linville; Annabel T Olson; Zhigang Wang; Matthew S Wiebe
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

3.  Dysregulation of Cellular VRK1, BAF, and Innate Immune Signaling by the Vaccinia Virus B12 Pseudokinase.

Authors:  Alexandria C Linville; Amber B Rico; Helena Teague; Lucy E Binsted; Geoffrey L Smith; Jonas D Albarnaz; Matthew S Wiebe
Journal:  J Virol       Date:  2022-05-11       Impact factor: 6.549

4.  Continued poxvirus research: From foe to friend.

Authors:  Susanna R Bidgood
Journal:  PLoS Biol       Date:  2019-01-30       Impact factor: 8.029

5.  A poxvirus pseudokinase represses viral DNA replication via a pathway antagonized by its paralog kinase.

Authors:  Annabel T Olson; Zhigang Wang; Amber B Rico; Matthew S Wiebe
Journal:  PLoS Pathog       Date:  2019-02-15       Impact factor: 6.823

6.  Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS-STING signalling.

Authors:  James B Eaglesham; Youdong Pan; Thomas S Kupper; Philip J Kranzusch
Journal:  Nature       Date:  2019-02-06       Impact factor: 69.504

7.  Vaccinia Virus Arrests and Shifts the Cell Cycle.

Authors:  Caroline K Martin; Jerzy Samolej; Annabel T Olson; Cosetta Bertoli; Matthew S Wiebe; Robertus A M de Bruin; Jason Mercer
Journal:  Viruses       Date:  2022-02-19       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.